Regulatory
Ziopharm Oncology’s Controlled IL-12 Platform Receives EMA’s COMP Positive Recommendation
Shots: EMA’s Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending Ziopharm’s Controlled IL-12 platform (Ad-RTS-hIL-12 + veledimex) for ODD candidate for the treatment of glioma EMA’s […]readmore